Please assess the completion status of the following clinical trial:

Trial Title: Evaluation of MRI and SPECT Fusion Software to Localize Parathyroid Adenomas

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: CASE_ONLY
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Subjects who are 18 years and over~* subjects who have had a failed parathyroidectomy and now presents with persistent hyperparathyroidism or recurrent hyperparathyroidism~* 6 control patients with parathyroid adenomas who have not yet had surgery will be selected to test the efficacy of the software.~Exclusion Criteria:~* Potential female subjects who are pregnant~* Any potential subject who has an implanted metallic device, stent or staples~* any subject weighing 300lb

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 80 Years
- Healthy Volunteers: f

Study Arms:
- 1 (Type: None): subjects who are diagnosed with parathyroid adenomas. There will be 6 subjects who have not had surgery and 25 subjects who have had surgery.

Based on this trial design, predict the completion outcome and termination type (if applicable).